Crossmark

Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study

Published Online: 2019-03-28

Published Print: 2019-12

Authors

Nambozi, Michael

Tinto, Halidou

Mwapasa, Victor

Tagbor, Harry

Kabuya, Jean-Bertin Bukasa

Hachizovu, Sebastian

Traoré, Maminata

Valea, Innocent

Tahita, Marc Christian

Ampofo, Gifty

Buyze, Jozefien

Ravinetto, Raffaella

Arango, Diana

Thriemer, Kamala

Mulenga, Modest

van Geertruyden, Jean-Pierre

D’Alessandro, Umberto https://orcid.org/0000-0001-6341-5009
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct00852423 at ClinicalTrials.gov

Documents that mention this clinical trial

Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study
https://doi.org/10.1186/s12936-019-2737-7
Funding

Funding for this research was provided by:

European and Developing Countries Clinical Trials Partnership (IP.2007.31080.001)

Bill and Melinda Gates Foundation
License Information

Text and Data Mining valid from 2019-03-28

Version of Record valid from 2019-03-28
More Information

Article History

Received: 2 August 2018

Accepted: 20 March 2019

First Online: 28 March 2019

Document is current